Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/14/2003CA2475187A1 Therapeutic polyesters and polyamides
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003CA2475071A1 Stabilization of protein preparations
08/14/2003CA2475066A1 Rhamnose binding protein
08/14/2003CA2475055A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003CA2474957A1 Methods for specific rapid detection of pathogenic food-relevant bacteria
08/14/2003CA2474778A1 A novel target to inhibit angiogenesis
08/14/2003CA2474695A1 Bioluminescent protease assay
08/14/2003CA2474652A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474145A1 Bacteriophage lysin
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473853A1 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2472765A1 Modulation of sulfate permease for photosynthetic hydrogen production
08/14/2003CA2472265A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003CA2467893A1 Modified antigen-presenting cells
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003CA2463478A1 Methods for screening osteogenic compounds
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1335022A1 Modification of plant cell wall component and method of regulating development differentiation
08/13/2003EP1335021A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
08/13/2003EP1335018A1 Sericin-containing material, process for producing the same and method of using the same
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334982A2 Solubilized complement receptor type 1 in crystal form
08/13/2003EP1334981A2 Method for purifying keratinocyte growth factors
08/13/2003EP1334980A1 Multimerized highly functional antifreeze protein
08/13/2003EP1334979A1 Gene conferring resistance to Phytophthera infestans (late-blight) in Solanaceae
08/13/2003EP1334727A2 Method for obtaining antigenic structures enhancing specific cross reactivity
08/13/2003EP1334659A1 Pd-1-lacking mouse and use thereof
08/13/2003EP1334362A1 Assays
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334200A2 Multiple inducible gene regulation system
08/13/2003EP1334197A1 Yeast derived vaccine against ipnv
08/13/2003EP1334196A2 Genomic fragment of streptococcus suis and clinical uses thereof
08/13/2003EP1334195A2 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334191A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334190A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334189A2 Molecules involved in the regulation of insulin resistance syndrome (irs)
08/13/2003EP1334188A2 Cd19-specific redirected immune cells
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334185A2 Method for producing proteins by electroporation
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334131A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
08/13/2003EP1334130A2 Regulation of human serotonin receptor precursor
08/13/2003EP1334129A2 Methods of screening for ltrpc2 modulators
08/13/2003EP1334128A2 New multimeric interferon beta polypeptides
08/13/2003EP1334127A1 Single-chain multimeric polypeptides
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334125A2 Human and mouse e2-protein, nucleic acids coding therefor and uses thereof
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins
08/13/2003EP1334121A2 A plant development regulating gene and its uses
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1334119A2 Compositions and methods for modulating rsv infection and immunity
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/13/2003EP1334116A1 A process of producing polyphenolic adhesive proteins and proteins produced in accordance with the process
08/13/2003EP1333871A1 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
08/13/2003EP1333861A2 Using heat shock proteins to increase immune response
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333849A2 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1066060B1 Mesenchymal stem cells as immunosuppressants
08/13/2003EP1012324A4 Promiscuous g-protein compositions and their use
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0820465B1 Bioprocess for production of dipeptide based compounds
08/13/2003EP0789587B1 Combined meningitis vaccine
08/13/2003EP0695361B1 Expression of heterologous genes according to a targeted expression profile
08/13/2003EP0669980B1 Method of controlling polypeptide production in bacteria
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0556344B1 New insulin-like growth factor binding protein
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003EP0470128B2 Active carbonates of polyalkylene oxides for modification of polypeptides
08/13/2003CN1436305A Hypotensors
08/13/2003CN1436246A Method for preparing physiologically active IL-18 polypeptide
08/13/2003CN1436238A Anti-listeria bacteriocin
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436236A Gasci基因 Gasci gene
08/13/2003CN1436235A Anti-angiogenic polypeptides
1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 2916